A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group
clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients
with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three
times a day for four weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Dong-A Pharmaceutical Co., Ltd. Dong-A ST Co., Ltd.